Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0179 | ||||
Gene Name | SLC25A2 | ||||
Protein Name | Mitochondrial ornithine transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | ORC2; ORNT2; SLC25A2; Solute carrier family 25 member 2 | ||||
DT Family | Mitochondrial Carrier (MC) Family ; | ||||
Tissue Specificity | Expressed in liver, kidney, pancreas andcultured fibroblasts. | ||||
Function | This transporter mediates ornithine transport across inner mitochondrial membrane, from the cytoplasm to the matrix. | ||||
Endogenous Substrate(s) | Citrulline; H+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Arginine
|
Approved | Drug Info | Growth hormone deficiency | 5A61 | [1] |
References | |||||
1 | Asymmetric dimethylarginine is transported by the mitochondrial carrier SLC25A2. Amino Acids. 2016 Feb;48(2):427-36. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.